Browsing Over 392 Presentations

Sort By
Novel clinical and translational insights in melanoma Educational session

Translational control of tumor immune escape via the eIF4F-STAT1-PD-L1 axis in melanoma (ID 86)

Lecture Time
09:00 - 09:20
Speakers
  • Stephan Vagner (Villejuif, Cedex, France)
Session Name
Novel clinical and translational insights in melanoma
Room
Room A
Date
Thu, Dec 8, 2022
Time
09:00 - 10:30
Haematological malignancies Educational session

Oncolytic virus therapy: A novel immunotherapeutic approach in haematologic malignancies (ID 380)

Lecture Time
11:25 - 11:50
Speakers
  • Kah-Whye Peng (Rochester, NY, United States of America)
Session Name
Haematological malignancies
Room
Room A
Date
Fri, Dec 9, 2022
Time
11:00 - 12:30
Mini Oral session 1 Mini Oral session

Invited Discussant (ID 414)

Lecture Time
10:00 - 10:10
Speakers
  • Benjamin Besse (Villejuif, CE, France)
Session Name
Mini Oral session 1
Room
Room C
Date
Thu, Dec 8, 2022
Time
09:00 - 10:10
Next generation technologies for the optimal implementation of immunotherapy Special session

Q&A (ID 37)

Lecture Time
17:15 - 17:30
Speakers
  • Solange Peters (Lausanne, Switzerland)
Session Name
Next generation technologies for the optimal implementation of immunotherapy
Room
Room C
Date
Thu, Dec 8, 2022
Time
16:00 - 17:30
Bristol Myers Squibb - Exploring new advancements in chemokine signaling in tumor biology: Focus on IL-8, CXCR1, and CXCR2 Industry satellite symposium

Emerging data for targeting IL-8, CXCR1, and/or CXCR2 as potential treatment options in solid tumors (ID 339)

Lecture Time
13:45 - 14:00
Speakers
  • Matteo Simonelli (Milan, Italy)
Session Name
Bristol Myers Squibb - Exploring new advancements in chemokine signaling in tumor biology: Focus on IL-8, CXCR1, and CXCR2
Room
Room A
Date
Thu, Dec 8, 2022
Time
13:15 - 14:15
Cancer vaccines: Promise or dead end? Controversy session

Introduction and first vote (ID 375)

Lecture Time
14:05 - 14:15
Speakers
  • Stephen P. Schoenberger (La Jolla, CA, United States of America)
Session Name
Cancer vaccines: Promise or dead end?
Room
Room A
Date
Wed, Dec 7, 2022
Time
14:05 - 15:05
Vesalius talk: Overcoming the fear of leading: How to become a leader in your research group Young Oncologists (YO) session

Panelist (ID 409)

Lecture Time
14:00 - 14:00
Speakers
  • Nicolas Girard (Paris, France)
Session Name
Vesalius talk: Overcoming the fear of leading: How to become a leader in your research group
Room
Room K
Date
Thu, Dec 8, 2022
Time
13:15 - 14:00
Welcome to the ESMO Immuno-Oncology Congress 2022 and Award Opening session

Overcoming resistance to immunotherapy: Targeting innate immune cells (ID 28)

Lecture Time
13:25 - 13:50
Speakers
  • Nina Bhardwaj (New York, NY, United States of America)
Session Name
Welcome to the ESMO Immuno-Oncology Congress 2022 and Award
Room
Room B
Date
Wed, Dec 7, 2022
Time
13:15 - 13:50
Joint ESMO-SITC Immunotherapy Primer Special session

Utilizing oncolytic virus as a new treatment modality (ID 76)

Lecture Time
10:10 - 10:30
Speakers
  • Ramon Alemany (Hospitalet de Llobregat, Spain)
Session Name
Joint ESMO-SITC Immunotherapy Primer
Room
Room C
Date
Wed, Dec 7, 2022
Time
09:00 - 12:30
Shared and neoantigen vaccines and T cells Educational session

Lessons learned from dendritic cell vaccines (ID 368)

Lecture Time
09:25 - 09:50
Speakers
  • Lisa H. Butterfield (San Francisco, CA, United States of America)
Session Name
Shared and neoantigen vaccines and T cells
Room
Room C
Date
Fri, Dec 9, 2022
Time
09:00 - 10:30
Bristol Myers Squibb - Exploring new advancements in chemokine signaling in tumor biology: Focus on IL-8, CXCR1, and CXCR2 Industry satellite symposium

Closing remarks and audience Q&A (ID 22)

Lecture Time
14:00 - 14:15
Speakers
  • Vincenzo Bronte (Verona, Italy)
Session Name
Bristol Myers Squibb - Exploring new advancements in chemokine signaling in tumor biology: Focus on IL-8, CXCR1, and CXCR2
Room
Room A
Date
Thu, Dec 8, 2022
Time
13:15 - 14:15
Sanofi and Regeneron - Current and future roles of immunotherapy in the treatment of advanced BCC and CSCC Industry satellite symposium

Shaping the future of immunotherapy in advanced BCC and CSCC (ID 71)

Lecture Time
18:20 - 18:35
Speakers
  • Marlies Wakkee (Rotterdam, Netherlands)
Session Name
Sanofi and Regeneron - Current and future roles of immunotherapy in the treatment of advanced BCC and CSCC
Room
Room A
Date
Wed, Dec 7, 2022
Time
17:45 - 18:45